Results 1 to 10 of about 3,816 (188)

Falsified and substandard medicines trafficking: A wakeup call for the African continent [PDF]

Public Health in Practice, 2022
While great effort is being placed on reducing disease burdens in Africa, the circulation of falsified and substandard medicines in the continent are reversing the hard-won gains.
Yusuf Hassan Wada
exaly   +6 more sources

Substandard and Falsified Medicines in Myanmar [PDF]

Pharmacy (Basel, Switzerland), 2020
Background: substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in ...
Naoko Yoshida, Tsuyoshi Tanimoto, Mohammad Sofiqur Rahman   +2 more
exaly   +5 more sources

Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: a scoping review [PDF]

Journal of Pharmaceutical Policy and Practice
Background The proliferation of substandard and falsified medical products (SFM) poses a significant threat to public health globally. Despite rigorous surveillance and law enforcement efforts, risk of exposure to SFM is on the rise, notably through ...
Lubna Merchant, Jean Christophe Rusatira, Saifuddin Ahmed   +2 more
exaly   +4 more sources

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country [PDF]

BMC Public Health, 2020
Background High prevalence of falsified, counterfeit and substandard medicines pose a threat to public health and treatment failure. This study aimed to investigate the quality of selected essential medicines available in Mongolia.
Daariimaa Khurelbat, Gereltuya Dorj, Bruce Sunderland, Tsetsegmaa Sanjjav, Enkhtuul Bayarsaikhan, Davaadagva Damdinjav, Gantuya Dorj, Altantuya Jigjidsuren, Oyun Lkhagvasuren, Baasandorj Erdenetsetseg   +9 more
doaj   +2 more sources

Recall of substandard medicines in Brazil during the period 2010-2018. [PDF]

BMC Health Serv Res, 2023
Background Even with all the care taken during the production process, the pharmaceutical industries are still subject to manufacturing medicines with quality deviations, generating commercialized products without the required quality and necessitating their subsequent recall from the market. The objective of this study
Oliveira CLCG, Machado VF, de Freitas Tavares H, Ribeiro GLM, Arrais PSD.   +4 more
europepmc   +4 more sources

Generic medicines are not substandard medicines [PDF]

Lancet, The, 2002
Sir—Carol Adelman and Jeremiah Norris (Dec 22/29, p 2174), who work for the industry-funded Hudson Institute, advocate the use of patented drugs, pointing to what they say are risks associated with generic drugs. They confuse generic drugs with old, substandard, ineffective, and counterfeit drugs. Generic does not mean old.
Carol Adelman, Jeremiah Norris
exaly   +5 more sources

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab. [PDF]

PLoS ONE, 2017
BackgroundSubstandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly
Albert Petersen, Nadja Held, Lutz Heide, Difäm-EPN Minilab Survey Group   +3 more
doaj   +2 more sources

A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines. [PDF]

PLOS Global Public Health
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market, and the true scale of the ...
Elizabeth Pisani, Ayu Rahmawati, Esti Mulatsari, Mawaddati Rahmi, William Nathanial, Yusi Anggriani, STARmeds Study Group   +6 more
doaj   +2 more sources

Substandard medicines: a greater problem than counterfeit medicines? [PDF]

BMJ Paediatr Open, 2017
Substandard medicines are medicines which have failed to pass the quality measurements and standards set for them.1 They should be distinguished from counterfeit (falsified) medicines which are deliberately and fraudulently mislabelled. Combining the two together however is not helpful.
Sammons HM, Choonara I.
europepmc   +4 more sources

Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines [PDF]

Frontiers in Pharmacology
Africa is a unique continent due to high disease burden for both communicable and non-communicable diseases, attracting large-scale distribution of medicines to tackle public health issues.
Billy Chabalenge, Tarsem Sahota, Irina Ermolina, Sangeeta Tanna   +3 more
doaj   +2 more sources